2019
DOI: 10.1007/s10461-019-02457-0
|View full text |Cite
|
Sign up to set email alerts
|

A Mixed-Methods Study Examining Adherence to and Acceptability of Intravaginal Rings for HIV Prevention: Behavioral Results of MTN-027

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
4
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 10 publications
(4 citation statements)
references
References 31 publications
0
4
0
Order By: Relevance
“…Following screening, 151 publications describing 123 studies with 34,740 ring users and 5,694 hypothetical users were included. Twenty-five studies were excluded from meta-analysis due to reporting product continuation without also reporting general acceptability [10,[28][29][30][31][32][33][34][35][36][37][38][39][40][41][42][43][44][45][46][47], reporting continuous rather than labelled categorical or dichotomous outcomes [48] and reporting preference data only [49,50] (Figure 1). Some secondary manuscripts of the included studies assessed acceptability across ring groups with different characteristics (e.g.…”
Section: Resultsmentioning
confidence: 99%
“…Following screening, 151 publications describing 123 studies with 34,740 ring users and 5,694 hypothetical users were included. Twenty-five studies were excluded from meta-analysis due to reporting product continuation without also reporting general acceptability [10,[28][29][30][31][32][33][34][35][36][37][38][39][40][41][42][43][44][45][46][47], reporting continuous rather than labelled categorical or dichotomous outcomes [48] and reporting preference data only [49,50] (Figure 1). Some secondary manuscripts of the included studies assessed acceptability across ring groups with different characteristics (e.g.…”
Section: Resultsmentioning
confidence: 99%
“…In two cases, however, the placement of the ring was uncomfortable. Several Phase I trials of other rings also reported some instances when women could feel the ring or might experience some cramping ( 16 , 27 ). In a Phase III trial of the dapivirine HIV prevention vaginal ring, participants reported experiencing heaviness and pelvic pain especially during initial months of the trial and equated this to improper placement of the ring.…”
Section: Discussionmentioning
confidence: 99%
“…In further testing of this VRV+MK-2048 prototype ring (a 48-subject Phase I trial to evaluate the safety, pharmacokinetics and pharmacodynamics of vaginal rings; dimensions 54 × 4 mm; similar to NuvaRing ® and Ornibel ® , Table 1), twelve women (25%) reported a single partial or complete involuntary expulsion of the ring, while two women (4.2%) reported two or more expulsions [191,192]. Expulsions generally occurred during menses, while urinating or during a bowel movement, and most participants were able to reinsert the ring immediately.…”
Section: Vicriviroc (Mk-4176) and Mk-2048mentioning
confidence: 99%